Consolidated Statements Of Cash Flows (Unaudited) (USD $)	3 Months Ended
	Aug. 31, 2014	Aug. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net Loss	$ (658,976)	$ (763,610)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	53,360	360
Common stock issued as compensation	55,350	453,825
Non cash interest expense	123,955	64,958
Loss (gain) on derivative valuation	192,890	(14,976)
Changes in Operating assets and liabilities:
Prepaid expenses		1
Accounts payable and accrued expenses	(4,801)	(10,509)
Accounts payable -related party	(21,366)
Net cash used in operating activities	(226,178)	(259,951)
CASH FLOWS FROM INVESTING ACTIVITIES
Cash paid for investments		(127,902)
Cash paid for loan receivable from consultant		(36,203)
Net cash used in investing activities		(164,105)
Total Comprehensive Loss	(11,650)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from convertible notes payable	128,448	282,500
Proceeds from loans payable to consultants and stockholders	108,885	155,199
Net cash provided by financing activities	237,333	437,699
Net increase(decrease) in cash and cash equivalents	(495)	13,643
CASH BALANCE BEGINNING OF PERIOD	460	20
CASH BALANCE/(BANK OVERDRAFT) END OF PERIOD	(35)	13,663
Cash paid for interest	20,424
Cash paid for taxes
SUPPLEMENTAL SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Shares issued for settlement of loans payable to consultants and stockholders	55,623
Shares issued for settlement of convertible notes payable	237,940	147,941
Shares issued for patent acquisition		35,500
Shares issued for equity interest in Imagic Ltd		$ 697,500